VPRIV 400 U, Pulver zur Herstellung einer Infusionslösung - Durchstechflasche(n) Swissmedic Key 61297002 Registration Holder Takeda Pharma AG Name VPRIV 400 U, Pulver zur Herstellung einer Infusionslösung Date of registration 29.08.2011 Introduction of Sequence 29.08.2011 ATC-Classification Velaglucerase Alfa (A16AB10) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.14. Show package size Durchstechflasche(n) Index Therapeuticus (Swissmedic) 07.14. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 1957.79 Limitation Yes Limitation text
Deductible 10 % Consumer price 2210.85 Feedback FB Daily cost GTIN 7680612970026 Medication Code Biotechnologika Pharmacode 4657286 Disponibility
Composition Praeparatio cryodesiccata: velaglucerasum alfa 400 U., saccharum, natrii citras dihydricus corresp. natrium 12.15 mg, acidum citricum monohydricum, polysorbatum 20, pro vitro. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form Lyophilisate Excipiens Active Agent Dose Velaglucerasum Alfa 400 U
BAG: Active Agent Dose Velaglucerasum Alfa 400 U
Inactive agents Citric Acid Monohydrate Natrii Citras Dihydricus Polysorbatum 20 Saccharum
Source Data was imported : 06.09.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
